Forty-eight outpatients (28 men/20 women: 35±11 (mean±SD) years) with schizophrenia (ICD-10: F20-29) were randomised to: 1) collaborative care group (TG), performing aerobic interval (AIT; 4×4-min treadmill walking/running at ∼90% peak heart rate) and leg press maximal strength training (MST; 4×4 repetitions at ∼90% maximal strength [1RM]) 2d·wk.-1 for 1-year, supported by transportation and training supervision; or 2) control group (CG). Peak oxygen uptake (V̇O2peak) and walking work efficiency were measured directly along with scaled 1RM/power, anthropometry, blood pressure, and blood samples at inclusion, 1-year, and 5-years post-intervention. The TG increased V̇O2peak (11%, p<.01), scaled 1RM (40%, p<.001), and power (26%, p<.001) compared to CG after 1-year. At follow-up, no intergroup differences in these factors were observed (all p>.05). Both groups improved walking work efficiency (TG: 11%; CG: 18%; both p<.05) after 1-year (no intergroup difference, p>.05), but not at follow-up (both p>.05). At follow-up, HDL (high-density lipoprotein)-cholesterol (-15%, p<.01) and glucose (26%, p<.01) decreased/increased(respectively) more in the TG than CG. No other intergroup differences were observed in anthropometry or blood samples. 1-year adherence-supported high-intensity training improves V̇O2peak, 1RM, and power in outpatients with schizophrenia. However, the improvements in these factors key to longevity are not maintained after 5years. These findings highlight the importance of long-lasting cost-efficient adherence support, ultimately affecting the population's prognosis.
Read full abstract